Loading VRTX…
Loading profile data…Frequently asked questions about VRTX
What does Vertex Pharmaceuticals Incorporated (VRTX) do?
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their c
Where does VRTX trade?
Vertex Pharmaceuticals Incorporated (VRTX) trades on the NASDAQ Global Select.
What sector is VRTX in?
Vertex Pharmaceuticals Incorporated (VRTX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Vertex Pharmaceuticals Incorporated?
Reshma Kewalramani is the chief executive officer of Vertex Pharmaceuticals Incorporated (VRTX).
Where is Vertex Pharmaceuticals Incorporated headquartered?
Vertex Pharmaceuticals Incorporated is headquartered in United States.
When did VRTX go public?
Vertex Pharmaceuticals Incorporated (VRTX) completed its initial public offering in 1991.